Which Pharma Stock Looks More Attractive: Sanofi or AbbVie?
Which Pharma Stock Looks More Attractive: Sanofi or AbbVie? Zacks Investment Research
Covered in this story
What has happened since
- Sanofi is up 1.9% since this was published, 6 days ago.
- AbbVie is up 2.0% since this was published, 6 days ago.
Price move measured from the close nearest publication to the latest quote.
Call it yourself
No calls on $SAN.PA yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Sanofi →Summary aggregated from Zacks Investment Research's public RSS feed. The full reporting belongs to Zacks Investment Research — please read it on their site.